Market Opportunity
Invida operates in the fastest growing healthcare market in the world, increasing at an annual compounded annual growth rate of 12 percent, more than double global growth for the sector.  Today, the Asia Pacific markets represent approximately US $50B and 10 percent of the worldwide pharmaceutical sales.

Core Competencies
Through an internally developed marketing process, EDGE™, Invida is able to guide products through the launch process, and support them throughout their lifecycle with a targeted, experienced sales and marketing team.

The Company operates in 13 markets across the Asia Pacific region, and provides a broad range of sales force coverage with over 3,500 sales experts covering hospitals, clinics and pharmacies

Regulatory and Medical Affairs
Invida has successfully submitted 40 new chemical entities (NCEs) since 2006 and holds over 1,000 licenses through its partners. 32 experts across the region perform the regulatory function while an established key opinion leader (KOL) network allows effective pre-marketing execution.  Invida’s in-house Phase IV capabilities and pharmacovigilance process are well-established and efficient.

Therapeutic Expertise
Invida operates effectively across a broad range of therapeutic areas: